APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pre-Exposure Prophylaxis (PrEP)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pre-Exposure Prophylaxis (PrEP) Market Analysis and Forecast 2026-2032

Report ID 174027820229 December 2025196 pages

Choose your research edition.

Industry ResearchPre-Exposure Prophylaxis (PrEP) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pre-Exposure Prophylaxis (PrEP) Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Pre-Exposure Prophylaxis (PrEP) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pre-Exposure Prophylaxis (PrEP) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pre-Exposure Prophylaxis (PrEP) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pre-Exposure Prophylaxis (PrEP) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pre-Exposure Prophylaxis (PrEP) include Amneal Pharmaceuticals, Aurobindo Pharma, Gilead Sciences, Mylan, Teva, ViiV Healthcare, Zydus, Anhui Baker Biopharmaceutical and Chengdu Brilliant Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pre-Exposure Prophylaxis (PrEP), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pre-Exposure Prophylaxis (PrEP), also provides the sales of main regions and countries. Of the upcoming market potential for Pre-Exposure Prophylaxis (PrEP), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pre-Exposure Prophylaxis (PrEP) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pre-Exposure Prophylaxis (PrEP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pre-Exposure Prophylaxis (PrEP) sales, projected growth trends, production technology, application and end-user industry.

Pre-Exposure Prophylaxis (PrEP) Segment by Company

Amneal Pharmaceuticals

Aurobindo Pharma

Gilead Sciences

Mylan

Teva

ViiV Healthcare

Zydus

Anhui Baker Biopharmaceutical

Chengdu Brilliant Pharmaceutical

North China Pharmaceutical

Qilu Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Pre-Exposure Prophylaxis (PrEP) Segment by Type

Oral PrEP

Injectable PrEP

Pre-Exposure Prophylaxis (PrEP) Segment by Application

Hospital and Clinic

Pharmacy

Other

Pre-Exposure Prophylaxis (PrEP) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Exposure Prophylaxis (PrEP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pre-Exposure Prophylaxis (PrEP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Exposure Prophylaxis (PrEP).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pre-Exposure Prophylaxis (PrEP) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pre-Exposure Prophylaxis (PrEP) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Exposure Prophylaxis (PrEP) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pre-Exposure Prophylaxis (PrEP) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral PrEP Major Manufacturers Table 3. Injectable PrEP Major Manufacturers Table 4. Global Pre-Exposure Prophylaxis (PrEP) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. Pre-Exposure Prophylaxis (PrEP) Industry Trends Table 9. Pre-Exposure Prophylaxis (PrEP) Industry Drivers Table 10. Pre-Exposure Prophylaxis (PrEP) Industry Opportunities and Challenges Table 11. Pre-Exposure Prophylaxis (PrEP) Industry Restraints Table 12. Global Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2021-2026) Table 16. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2027-2032) Table 17. Global Pre-Exposure Prophylaxis (PrEP) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (2021-2026) & (K Units) Table 19. Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (2027-2032) & (K Units) Table 20. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2021-2026) Table 21. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2027-2032) Table 22. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pre-Exposure Prophylaxis (PrEP) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pre-Exposure Prophylaxis (PrEP) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Pre-Exposure Prophylaxis (PrEP) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pre-Exposure Prophylaxis (PrEP) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pre-Exposure Prophylaxis (PrEP) Manufacturers, Product Type & Application Table 30. Global Pre-Exposure Prophylaxis (PrEP) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pre-Exposure Prophylaxis (PrEP) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2021-2026) Table 37. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2027-2032) Table 38. Global Pre-Exposure Prophylaxis (PrEP) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2026) & (K Units) Table 40. Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027-2032) & (K Units) Table 41. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2021-2026) Table 42. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2027-2032) Table 43. Global Pre-Exposure Prophylaxis (PrEP) Price by Type (2021-2026) & (US$/Unit) Table 44. Global Pre-Exposure Prophylaxis (PrEP) Price by Type (2027-2032) & (US$/Unit) Table 45. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2021-2026) Table 49. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2027-2032) Table 50. Global Pre-Exposure Prophylaxis (PrEP) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2026) & (K Units) Table 52. Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027-2032) & (K Units) Table 53. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2021-2026) Table 54. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2027-2032) Table 55. Global Pre-Exposure Prophylaxis (PrEP) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pre-Exposure Prophylaxis (PrEP) Price by Application (2027-2032) & (US$/Unit) Table 57. Amneal Pharmaceuticals Company Information Table 58. Amneal Pharmaceuticals Business Overview Table 59. Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 61. Amneal Pharmaceuticals Recent Development Table 62. Aurobindo Pharma Company Information Table 63. Aurobindo Pharma Business Overview Table 64. Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 66. Aurobindo Pharma Recent Development Table 67. Gilead Sciences Company Information Table 68. Gilead Sciences Business Overview Table 69. Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 71. Gilead Sciences Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Mylan Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 76. Mylan Recent Development Table 77. Teva Company Information Table 78. Teva Business Overview Table 79. Teva Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 81. Teva Recent Development Table 82. ViiV Healthcare Company Information Table 83. ViiV Healthcare Business Overview Table 84. ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 86. ViiV Healthcare Recent Development Table 87. Zydus Company Information Table 88. Zydus Business Overview Table 89. Zydus Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Zydus Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 91. Zydus Recent Development Table 92. Anhui Baker Biopharmaceutical Company Information Table 93. Anhui Baker Biopharmaceutical Business Overview Table 94. Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 96. Anhui Baker Biopharmaceutical Recent Development Table 97. Chengdu Brilliant Pharmaceutical Company Information Table 98. Chengdu Brilliant Pharmaceutical Business Overview Table 99. Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 101. Chengdu Brilliant Pharmaceutical Recent Development Table 102. North China Pharmaceutical Company Information Table 103. North China Pharmaceutical Business Overview Table 104. North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 106. North China Pharmaceutical Recent Development Table 107. Qilu Pharmaceutical Company Information Table 108. Qilu Pharmaceutical Business Overview Table 109. Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 111. Qilu Pharmaceutical Recent Development Table 112. Chia Tai Tianqing Pharmaceutical Company Information Table 113. Chia Tai Tianqing Pharmaceutical Business Overview Table 114. Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio Table 116. Chia Tai Tianqing Pharmaceutical Recent Development Table 117. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2026) & (K Units) Table 120. North America Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027-2032) & (K Units) Table 121. North America Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2026) & (K Units) Table 126. North America Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027-2032) & (K Units) Table 127. North America Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021-2026) & (K Units) Table 134. North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2027-2032) & (K Units) Table 135. North America Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 138. Canada Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 139. Mexico Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 140. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2026) & (K Units) Table 143. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027-2032) & (K Units) Table 144. Europe Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Europe Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2026) & (K Units) Table 149. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027-2032) & (K Units) Table 150. Europe Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Europe Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 156. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021-2026) & (K Units) Table 157. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (2027-2032) & (K Units) Table 158. Europe Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Europe Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Germany Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 161. France Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 162. U.K. Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 163. Italy Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 164. Russia Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 165. Spain Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 168. Sweden Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 169. Poland Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 170. China Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2026) & (US$ Million) Table 171. China Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027-2032) & (US$ Million) Table 172. China Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2026) & (K Units) Table 173. China Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027-2032) & (K Units) Table 174. China Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2026) & (US$ Million) Table 177. China Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027-2032) & (US$ Million) Table 178. China Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2026) & (K Units) Table 179. China Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027-2032) & (K Units) Table 180. China Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2026) & (K Units) Table 185. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027-2032) & (K Units) Table 186. Asia Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2026) & (K Units) Table 191. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027-2032) & (K Units) Table 192. Asia Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021-2026) & (K Units) Table 199. Asia Pre-Exposure Prophylaxis (PrEP) Sales by Country (2027-2032) & (K Units) Table 200. Asia Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 203. South Korea Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 204. India Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 205. Australia Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 229. Argentina Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 230. Chile Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 231. Colombia Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 232. Peru Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 234. Israel Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 235. UAE Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 236. Turkey Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 237. Iran Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 238. Egypt Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Pre-Exposure Prophylaxis (PrEP) Distributors List Table 242. Pre-Exposure Prophylaxis (PrEP) Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Pre-Exposure Prophylaxis (PrEP) Image Figure 2. Global Pre-Exposure Prophylaxis (PrEP) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pre-Exposure Prophylaxis (PrEP) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral PrEP Image Figure 5. Injectable PrEP Image Figure 6. Global Pre-Exposure Prophylaxis (PrEP) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pre-Exposure Prophylaxis (PrEP) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Pre-Exposure Prophylaxis (PrEP) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pre-Exposure Prophylaxis (PrEP) Revenue (2021-2032) & (US$ Million) Figure 13. Global Pre-Exposure Prophylaxis (PrEP) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2021-2032) Figure 16. Global Pre-Exposure Prophylaxis (PrEP) Sales (2021-2032) & (K Units) Figure 17. Global Pre-Exposure Prophylaxis (PrEP) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pre-Exposure Prophylaxis (PrEP) Sales YoY (2021-2032) & (K Units) Figure 20. Europe Pre-Exposure Prophylaxis (PrEP) Sales YoY (2021-2032) & (K Units) Figure 21. China Pre-Exposure Prophylaxis (PrEP) Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Pre-Exposure Prophylaxis (PrEP) Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales YoY (2021-2032) & (K Units) Figure 24. Global Pre-Exposure Prophylaxis (PrEP) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pre-Exposure Prophylaxis (PrEP) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2021-2032) Figure 30. Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2021-2032) Figure 33. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2021-2032) Figure 36. Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2021-2032) Figure 39. North America Pre-Exposure Prophylaxis (PrEP) Revenue Share by Type (2021-2032) Figure 40. North America Pre-Exposure Prophylaxis (PrEP) Sales Share by Type (2021-2032) Figure 41. North America Pre-Exposure Prophylaxis (PrEP) Revenue Share by Application (2021-2032) Figure 42. North America Pre-Exposure Prophylaxis (PrEP) Sales Share by Application (2021-2032) Figure 43. North America Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country (2021-2032) Figure 44. North America Pre-Exposure Prophylaxis (PrEP) Sales Share by Country (2021-2032) Figure 45. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Share by Type (2021-2032) Figure 46. Europe Pre-Exposure Prophylaxis (PrEP) Sales Share by Type (2021-2032) Figure 47. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Share by Application (2021-2032) Figure 48. Europe Pre-Exposure Prophylaxis (PrEP) Sales Share by Application (2021-2032) Figure 49. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country (2021-2032) Figure 50. Europe Pre-Exposure Prophylaxis (PrEP) Sales Share by Country (2021-2032) Figure 51. China Pre-Exposure Prophylaxis (PrEP) Revenue Share by Type (2021-2032) Figure 52. China Pre-Exposure Prophylaxis (PrEP) Sales Share by Type (2021-2032) Figure 53. China Pre-Exposure Prophylaxis (PrEP) Revenue Share by Application (2021-2032) Figure 54. China Pre-Exposure Prophylaxis (PrEP) Sales Share by Application (2021-2032) Figure 55. Asia Pre-Exposure Prophylaxis (PrEP) Revenue Share by Type (2021-2032) Figure 56. Asia Pre-Exposure Prophylaxis (PrEP) Sales Share by Type (2021-2032) Figure 57. Asia Pre-Exposure Prophylaxis (PrEP) Revenue Share by Application (2021-2032) Figure 58. Asia Pre-Exposure Prophylaxis (PrEP) Sales Share by Application (2021-2032) Figure 59. Asia Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country (2021-2032) Figure 60. Asia Pre-Exposure Prophylaxis (PrEP) Sales Share by Country (2021-2032) Figure 61. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Share by Type (2021-2032) Figure 62. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Share by Type (2021-2032) Figure 63. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Share by Application (2021-2032) Figure 64. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Share by Application (2021-2032) Figure 65. SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country (2021-2032) Figure 66. SAMEA Pre-Exposure Prophylaxis (PrEP) Sales Share by Country (2021-2032) Figure 67. Pre-Exposure Prophylaxis (PrEP) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pre-Exposure Prophylaxis (PrEP) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral PrEP
  • Injectable PrEP
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Amneal Pharmaceuticals
  • Aurobindo Pharma
  • Gilead Sciences
  • Mylan
  • Teva
  • ViiV Healthcare
  • Zydus
  • Anhui Baker Biopharmaceutical
  • Chengdu Brilliant Pharmaceutical
  • North China Pharmaceutical
  • Qilu Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pre-Exposure Prophylaxis (PrEP) Market by Type
  3. 1.2.1 Global Pre-Exposure Prophylaxis (PrEP) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral PrEP
  5. 1.2.3 Injectable PrEP
  6. 1.3 Pre-Exposure Prophylaxis (PrEP) Market by Application
  7. 1.3.1 Global Pre-Exposure Prophylaxis (PrEP) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pre-Exposure Prophylaxis (PrEP) Market Dynamics
  1. 2.1 Pre-Exposure Prophylaxis (PrEP) Industry Trends
  2. 2.2 Pre-Exposure Prophylaxis (PrEP) Industry Drivers
  3. 2.3 Pre-Exposure Prophylaxis (PrEP) Industry Opportunities and Challenges
  4. 2.4 Pre-Exposure Prophylaxis (PrEP) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region
  3. 3.2.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2021-2026)
  5. 3.2.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2027-2032)
  6. 3.2.4 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region
  9. 3.4.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (2021-2026)
  11. 3.4.3 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (2027-2032)
  12. 3.4.4 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Manufacturers
  2. 4.1.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pre-Exposure Prophylaxis (PrEP) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Manufacturers
  6. 4.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pre-Exposure Prophylaxis (PrEP) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pre-Exposure Prophylaxis (PrEP) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pre-Exposure Prophylaxis (PrEP) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pre-Exposure Prophylaxis (PrEP) Manufacturers, Product Type & Application
  13. 4.7 Global Pre-Exposure Prophylaxis (PrEP) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pre-Exposure Prophylaxis (PrEP) Market CR5 and HHI
  16. 4.8.2 2025 Pre-Exposure Prophylaxis (PrEP) Tier 1, Tier 2, and Tier 3
5 Pre-Exposure Prophylaxis (PrEP) Market by Type
  1. 5.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type
  2. 5.1.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type
  6. 5.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pre-Exposure Prophylaxis (PrEP) Price by Type
6 Pre-Exposure Prophylaxis (PrEP) Market by Application
  1. 6.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application
  2. 6.1.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application
  6. 6.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pre-Exposure Prophylaxis (PrEP) Price by Application
7 Company Profiles
  1. 7.1 Amneal Pharmaceuticals
  2. 7.1.1 Amneal Pharmaceuticals Company Information
  3. 7.1.2 Amneal Pharmaceuticals Business Overview
  4. 7.1.3 Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  6. 7.1.5 Amneal Pharmaceuticals Recent Developments
  7. 7.2 Aurobindo Pharma
  8. 7.2.1 Aurobindo Pharma Company Information
  9. 7.2.2 Aurobindo Pharma Business Overview
  10. 7.2.3 Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  12. 7.2.5 Aurobindo Pharma Recent Developments
  13. 7.3 Gilead Sciences
  14. 7.3.1 Gilead Sciences Company Information
  15. 7.3.2 Gilead Sciences Business Overview
  16. 7.3.3 Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  18. 7.3.5 Gilead Sciences Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Teva
  26. 7.5.1 Teva Company Information
  27. 7.5.2 Teva Business Overview
  28. 7.5.3 Teva Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teva Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  30. 7.5.5 Teva Recent Developments
  31. 7.6 ViiV Healthcare
  32. 7.6.1 ViiV Healthcare Company Information
  33. 7.6.2 ViiV Healthcare Business Overview
  34. 7.6.3 ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  36. 7.6.5 ViiV Healthcare Recent Developments
  37. 7.7 Zydus
  38. 7.7.1 Zydus Company Information
  39. 7.7.2 Zydus Business Overview
  40. 7.7.3 Zydus Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Zydus Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  42. 7.7.5 Zydus Recent Developments
  43. 7.8 Anhui Baker Biopharmaceutical
  44. 7.8.1 Anhui Baker Biopharmaceutical Company Information
  45. 7.8.2 Anhui Baker Biopharmaceutical Business Overview
  46. 7.8.3 Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  48. 7.8.5 Anhui Baker Biopharmaceutical Recent Developments
  49. 7.9 Chengdu Brilliant Pharmaceutical
  50. 7.9.1 Chengdu Brilliant Pharmaceutical Company Information
  51. 7.9.2 Chengdu Brilliant Pharmaceutical Business Overview
  52. 7.9.3 Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  54. 7.9.5 Chengdu Brilliant Pharmaceutical Recent Developments
  55. 7.10 North China Pharmaceutical
  56. 7.10.1 North China Pharmaceutical Company Information
  57. 7.10.2 North China Pharmaceutical Business Overview
  58. 7.10.3 North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  60. 7.10.5 North China Pharmaceutical Recent Developments
  61. 7.11 Qilu Pharmaceutical
  62. 7.11.1 Qilu Pharmaceutical Company Information
  63. 7.11.2 Qilu Pharmaceutical Business Overview
  64. 7.11.3 Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  66. 7.11.5 Qilu Pharmaceutical Recent Developments
  67. 7.12 Chia Tai Tianqing Pharmaceutical
  68. 7.12.1 Chia Tai Tianqing Pharmaceutical Company Information
  69. 7.12.2 Chia Tai Tianqing Pharmaceutical Business Overview
  70. 7.12.3 Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
  72. 7.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Pre-Exposure Prophylaxis (PrEP) Market Size by Type
  2. 8.1.1 North America Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2032)
  3. 8.1.2 North America Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2032)
  4. 8.1.3 North America Pre-Exposure Prophylaxis (PrEP) Price by Type (2021-2032)
  5. 8.2 North America Pre-Exposure Prophylaxis (PrEP) Market Size by Application
  6. 8.2.1 North America Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2032)
  7. 8.2.2 North America Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2032)
  8. 8.2.3 North America Pre-Exposure Prophylaxis (PrEP) Price by Application (2021-2032)
  9. 8.3 North America Pre-Exposure Prophylaxis (PrEP) Market Size by Country
  10. 8.3.1 North America Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pre-Exposure Prophylaxis (PrEP) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pre-Exposure Prophylaxis (PrEP) Market Size by Type
  2. 9.1.1 Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2032)
  4. 9.1.3 Europe Pre-Exposure Prophylaxis (PrEP) Price by Type (2021-2032)
  5. 9.2 Europe Pre-Exposure Prophylaxis (PrEP) Market Size by Application
  6. 9.2.1 Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2032)
  8. 9.2.3 Europe Pre-Exposure Prophylaxis (PrEP) Price by Application (2021-2032)
  9. 9.3 Europe Pre-Exposure Prophylaxis (PrEP) Market Size by Country
  10. 9.3.1 Europe Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pre-Exposure Prophylaxis (PrEP) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pre-Exposure Prophylaxis (PrEP) Market Size by Type
  2. 10.1.1 China Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2032)
  3. 10.1.2 China Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2032)
  4. 10.1.3 China Pre-Exposure Prophylaxis (PrEP) Price by Type (2021-2032)
  5. 10.2 China Pre-Exposure Prophylaxis (PrEP) Market Size by Application
  6. 10.2.1 China Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2032)
  7. 10.2.2 China Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2032)
  8. 10.2.3 China Pre-Exposure Prophylaxis (PrEP) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pre-Exposure Prophylaxis (PrEP) Market Size by Type
  2. 11.1.1 Asia Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2032)
  4. 11.1.3 Asia Pre-Exposure Prophylaxis (PrEP) Price by Type (2021-2032)
  5. 11.2 Asia Pre-Exposure Prophylaxis (PrEP) Market Size by Application
  6. 11.2.1 Asia Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2032)
  8. 11.2.3 Asia Pre-Exposure Prophylaxis (PrEP) Price by Application (2021-2032)
  9. 11.3 Asia Pre-Exposure Prophylaxis (PrEP) Market Size by Country
  10. 11.3.1 Asia Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pre-Exposure Prophylaxis (PrEP) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pre-Exposure Prophylaxis (PrEP) Market Size by Type
  2. 12.1.1 SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pre-Exposure Prophylaxis (PrEP) Price by Type (2021-2032)
  5. 12.2 SAMEA Pre-Exposure Prophylaxis (PrEP) Market Size by Application
  6. 12.2.1 SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pre-Exposure Prophylaxis (PrEP) Price by Application (2021-2032)
  9. 12.3 SAMEA Pre-Exposure Prophylaxis (PrEP) Market Size by Country
  10. 12.3.1 SAMEA Pre-Exposure Prophylaxis (PrEP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pre-Exposure Prophylaxis (PrEP) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pre-Exposure Prophylaxis (PrEP) Value Chain Analysis
  2. 13.1.1 Pre-Exposure Prophylaxis (PrEP) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pre-Exposure Prophylaxis (PrEP) Production Mode & Process
  6. 13.2 Pre-Exposure Prophylaxis (PrEP) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pre-Exposure Prophylaxis (PrEP) Distributors
  9. 13.2.3 Pre-Exposure Prophylaxis (PrEP) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst